| Home > Publications Database > The life-saving benefit of dexamethasone in severe COVID-19 is linked to a reversal of monocyte dysregulation. > Access to Fulltext |
DZNE-2024-01024
|
|||||||
| version 1 |
| ||||||
| Restricted | |||||||||||||
DZNE-2024-01024 SUP
|
|||||||||||||
| version 1 |
| ||||||||||||